Epigenetic drugs induce the potency of classic chemotherapy, suppress post-treatment re-growth of breast cancer, but preserve the wound healing ability of stem cells

Epigenetic drugs induce the potency of classic chemotherapy, suppress post-treatment re-growth of breast cancer, but preserve the wound healing ability of stem cells

Epigenetic therapy augments neoadjuvant chemotherapy (NACT) in breast cancer and may aid post-surgical wound healing affected by NACT. Our study investigates: (1) The cytotoxicity of classic paclitaxel chemotherapy on triple negative breast cancer (TNBC) independently and in combination with epigene...

Full description

Bibliographic Details
Main Authors: Andrew Zheng, Michelle Bilbao, Janhvi Sookram, Kimberly M. Linden, Andrew B. Morgan, Olga Ostrovsky
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Cancer Biology & Therapy
Subjects:
triple negative breast cancer
epigenetic drugs
adipose-derived stem cells
wound healing
neoadjuvant chemotherapy
breast conserving therapy
Online Access:http://dx.doi.org/10.1080/15384047.2022.2052540

Internet

http://dx.doi.org/10.1080/15384047.2022.2052540

Similar Items